Study of quality of life in patients with seborrheic keratosis using different treatment regimens

Keywords: seborrheic keratosis, dermatological quality of life, dyschromia, scarring, topical oxidant


Objective of this work is to evaluate the effect of a new topical treatment scheme for seborrheic keratosis on the quality of life in comparison with invasive electrocoagulation technique in terms of secondary changes in the skin (dyschromia, scarring).

Materials and methods. 90 patients with seborrheic keratoses (77 females (85.6%), 13 males (14.4%)) were examined at the "University Clinic" and the Department of Dermatovenerology and Cosmetology with the Course of Aesthetic Medicine of FPE of ZSMU. Clinical, dermatoscopic, ultrasound, and pathomorphological examinations were performed for diagnostic purposes. The patients were randomly allocated into 2 groups. Local therapy was recommended as treatment for the first group (n=60). Patients in the second group (n=30) were prescribed electrocoagulation to remove neoplasms. Quality of life was assessed using the standardized DLQI index. The degree of discomfort with the application of a 30% hydrogen peroxide solution was assessed using a visual analog scale.

Results. Only 13 patients (21,66%) in Group I had secondary skin changes in the form of hypopigmentation. At the same time 26 (86,66%) patients of Group II had an undesirable result after removal in the form of scar changes. Assessment of quality of life also indicates a significant difference when comparing topical and invasive treatment. According to the questionnaire results, patients in the main group had a score of 5 (4;6), whereas in the case of electrocoagulation removal the score was 7 (6;9) (U=373.5; p=0,000005).

Conclusions. The use of topical agents in the treatment of seborrheic keratosis demonstrates effective efficacy in the extent of skin clearing of these neoplasms.


Smith SR, Xu S, Estes E, Shanler SD. Anatomic Site-Specific Treatment Response With 40% Hydrogen Peroxide (W/W) Topical Formulation for Raised Seborrheic Keratoses: Pooled Analysis of Data From Two Phase 3 Studies. J Drugs Dermatol. 2018; 17(10) :1092-1098.

Lacarrubba F, Nasca MR, Verzì AE, Micali G . A Novel Topical Agent in the Treatment of Seborrheic Keratoses: A Proof of Concept Study by Clinical and Dermoscopic Evaluation. Dermatol Ther . 2017; 30(5). doi: 10.1111/dth.12526.

DuBois JC, Jarratt M, Beger BB, Bradshaw M et al. A-101, a Proprietary Topical Formulation of High-Concentration Hydrogen Peroxide Solution: A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Dose-Response Profile in Subjects With Seborrheic Keratosis of the Face. Dermatol Surg . 2018; 44(3):330-340. doi: 10.1097/DSS.0000000000001302.

Bruscino N, Conti R, Campolmi P, Bonan P Dermatosis Papulosa Nigra and 10,600-nm CO2 laser, a good choice. J Cosmet Laser Ther. 2014;16(3) :114-6. doi: 10.3109/14764172.2013.854640.

Karadag AS, Ozkanli Ş, Mansuroglu C, Ozlu E. Effectiveness of the Pulse Dye Laser Treatment in a Caucasian Women With Dermatosis Papulosa Nigra. Indian J Dermatol. 2015; 60(3) :321. doi: 10.4103/0019-5154.156447.

Wood LD, Stucki JK, Hollenbeak CS, Miller JJ. Effectiveness of cryosurgery vs curettage in the treatment of seborrheic keratoses. JAMA Dermatol. 2013; 108-9. doi: 10.1001/2013.jamadermatol.275.

Gurel MS, Aral BB. Effectiveness of erbium:YAG laser and cryosurgery in seborrheic keratoses: Randomized, prospective intraindividual comparison study. J Dermatolog Treat. 2015; 477-80. doi: 10.3109/09546634.2015.1024597.

Pizzini L, Luca GD, Milani M. Efficacy and Tolerability of Topical Polyphenon E in Multiple "Seborrheic Keratosis-Like" Lesions of the Groin in an Immunocompetent 26-Year-Old Man. Case Rep Dermatol . 2019; 11(3):310-316. doi: 10.1159/000503989.

Klaus MV, Wehr RF, Rogers RS, Russell TJ et. al.Evaluation of Ammonium Lactate in the Treatment of Seborrheic Keratoses. J Am Acad Dermatol . 1990; 22(2 Pt 1):199-203.

Kao S, Kiss A, Efimova T, Friedman A. Ex Vivo Evaluation of Cytotoxicity and Melanocyte Viability After A-101 Hydrogen Peroxide Topical Solution 40% or Cryosurgery Treatment in Seborrheic Keratosis Lesions. J Am Acad Dermatol . 2018; 9(4):767-768. doi: 10.1016/j.jaad.2018.03.034

Baumann LS, Blauvelt A, Draelos ZD, Kempers SE Safety and Efficacy of Hydrogen Peroxide Topical Solution, 40% (W/W), in Patients With Seborrheic Keratoses: Results From 2 Identical, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (A-101-SEBK-301/302). J Am Acad Dermatol. 2018; 79(5):869-877.

doi: 10.1016/j.jaad.2018.05.044.

Herron MD, Bowen AR, Krueger GG. Seborrheic keratoses: a study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimod. Int J Dermatol. 2004; 43(4) :300-2. doi: 10.1111/j.1365-4632.2004.02282.x

Furukawa F, Mizawa M, Shimizu T.Treatment of dermatosis papulosa nigra using a carbon dioxide laser.J Cosmet Dermatol. 2020. doi: 10.1111/jocd.13309.

Schweiger ES, Kwasniak L, Aires DJ. Тreatment of dermatosis papulosa nigra with a 1064 nm Nd:YAG laser: report of two cases. J Cosmet Laser Ther. 2008; 10(2) :120-2. doi: 10.1080/14764170801950070.

Polder KD, Mithani A,.Harrison A, Bruce S.Treatment of macular seborrheic keratoses using a novel 1927-nm fractional thulium fiber laser. Dermatol Surg. 2012; 38(7 Pt 1):1025-31. doi: 10.1111/j.1524-4725.2012.02427.x

How to Cite
Makurina, G. I., & Cherneda, L. O. (2022). Study of quality of life in patients with seborrheic keratosis using different treatment regimens. Modern Medical Technology, (2(53), 55-60.
Original research